Lensar Inc Reports Results For The Quarter Ended June 30: Earnings Summary

LENSAR

13/08/2026 14:31

LENSAR Inc LNSR.OQ reported quarterly adjusted earnings of 10 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -15 cents.  The mean expectation of two analysts for the quarter was for a loss of 16 cents per share. Wall Street expected results to range from -22 cents to -11 cents per share.
Revenue rose 18.4% to $16.50 million from a year ago; analysts expected $14.65 million. 
LENSAR Inc's reported EPS for the quarter was 10 cents​.
The company reported quarterly net income of $3.54 million.
LENSAR Inc shares had risen by 10.2% this quarter and lost 45.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is  "buy."
Wall Street's median 12-month price target for LENSAR Inc is $8.50, about 26% above its last closing price of $6.29
This summary was machine generated from LSEG data August 13 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.16
0.10
Beat
Mar. 31 2026 
0.19
0.00
Missed
Dec. 31 2025 
-0.07
-0.12
Missed
Sep. 30 2025 
-0.05
-0.31
Missed